(Q33754246)

29 July 2017

title

Inhibition of carnitine palymitoyltransferase1b induces cardiac hypertrophy and mortality in mice (English)

1 reference

29 July 2017

K R Haynie

1

1 reference

29 July 2017

B Vandanmagsar

2

1 reference

29 July 2017

S E Wicks

3

1 reference

29 July 2017

J Zhang

4

1 reference

29 July 2017

R L Mynatt

5

1 reference

29 July 2017

publication date

16 January 2014

1 reference

Diabetes, Obesity and Metabolism

29 July 2017

published in

1 reference

29 July 2017

volume

16

1 reference

29 July 2017

issue

8

1 reference

29 July 2017

page(s)

757-760

1 reference

Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057362

Augmenting muscle diacylglycerol and triacylglycerol content by blocking fatty acid oxidation does not impede insulin sensitivity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057362

In obese Zucker rats, lipids accumulate in the heart despite normal mitochondrial content, morphology and long-chain fatty acid oxidation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057362

Etomoxir-induced partial carnitine palmitoyltransferase-I (CPT-I) inhibition in vivo does not alter cardiac long-chain fatty acid uptake and oxidation rates.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057362

Animal models of steatosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057362

Carnitine palmitoyltransferase deficiencies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057362

Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FDOM.12248

Down-regulation of acyl-CoA oxidase gene expression and increased NF-kappaB activity in etomoxir-induced cardiac hypertrophy.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FDOM.12248

Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4057362

Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24330405

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/DOM.12248

1 reference

29 July 2017

1 reference

29 July 2017

1 reference